https://bay2666605inhibitor.co....m/solution-dissolvab
HKP was verified to keep up the bioactivity associated with parent medication for ameliorating ischemia-reperfusion injury by lowering brain infarction and improving neurologic purpose. Taken collectively, HKP is a potentially useful aqueous-soluble prodrug with enhanced pharmacokinetic properties which may merit further development as a possible medication applicant. © 2018 Shenyang Pharmaceutical University. Posted by Elsevier B.V.Monocarboxylate transporter 1 (
Like
Comment
Share